CIK: 1490283 - Address: C/O Camp4 Therapeutics Corporation, One Kendall Sq., Bldg 1400 West, 3Rd Fl., Cambridge, MA 02139
25 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
S%ret1110-3-1110-18-8
S%wins100100100010010083

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
9/18/24 17:00
9/16/24
SYRSSyros Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYoung Richard AMADM.d00.00033311D
7/2/24 16:15
6/28/24
SYRSSyros Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYoung Richard AMADS-1785.120-35-818D
9/19/23 16:48
9/16/23
SYRSSyros Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYoung Richard AMADM.d00.0003739D
6/5/23 16:15
6/2/23
OMGAOmega Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagYoung Richard AMADS-408.000-5-1739D
5/3/23 16:05
5/1/23
OMGAOmega Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagYoung Richard AMADS-408.000-5-1744D
4/10/23 16:05
4/6/23
OMGAOmega Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagYoung Richard AMADS-408.000-5-1749D
3/20/23 16:05
3/17/23
OMGAOmega Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagYoung Richard AMADS-808.000-10-1754D
1/11/23 16:14
1/10/23
OMGAOmega Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagYoung Richard AMADS-1608.000-20-3764D
9/15/22 16:10
9/14/22
OMGAOmega Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagYoung Richard AMADS-808.000-10-1784D
2/18/21 17:34
2/16/21
SYRSSyros Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYoung Richard AMADS-4512.050-4-1322D
2/10/21 17:29
2/8/21
SYRSSyros Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYoung Richard AMADS-4913.040-4-1325D
2/10/21 17:28
11/16/20
SYRSSyros Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYoung Richard AMADS.am-538.770-6-2329D
11/18/20 16:33
11/16/20
SYRSSyros Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYoung Richard AMADS.m-538.770-6-2339D
10/19/20 18:36
10/19/20
SYRSSyros Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYoung Richard AMADS-508.750-6-2335D
10/16/20 16:39
10/15/20
SYRSSyros Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYoung Richard AMADS-38.75000341D
9/16/20 08:32
9/15/20
SYRSSyros Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYoung Richard AMADS-6210.390-6-2341D
8/19/20 16:33
8/17/20
SYRSSyros Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYoung Richard AMADS-7512.590-6-2347D
7/17/20 16:11
7/15/20
SYRSSyros Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYoung Richard AMADS-7111.850-6-2353D
6/16/20 16:53
6/15/20
SYRSSyros Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYoung Richard AMADS-528.750-6-2359D
5/15/20 17:13
5/15/20
SYRSSyros Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYoung Richard AMADS-559.220-6-2365D
4/17/20 16:02
4/15/20
SYRSSyros Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYoung Richard AMADS-2108.750-24-6371D
8/19/19 16:08
8/15/19
SYRSSyros Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYoung Richard AMADS.m-25010.000-25-6395D
8/16/17 16:08
8/14/17
SYRSSyros Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYoung Richard AMADS-7222.000-3-1420D
7/27/17 16:09
7/25/17
SYRSSyros Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYoung Richard AMADS-7222.090-3-1423D
3/16/12 15:29
3/15/12
ENZNEnzon Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagYoung Richard ANJDS-146.922-2-920D-30-32-150-9-8310-3-1110-18

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact